The recent meta-analysis by Wang et al. pooled the data of 8 case-control studies and indicated the CYP1A1 Ile462Val polymorphism might be a risk factor for cervical cancer (Wang et al., 2015). This evidence concerns the gene CYP1A1 and cervical cancer.